Provided are compounds comprising a first ligand L.sub.A; wherein L.sub.A comprises a 5-membered heterocycle joined to a metal M by a M-C or M-N bond; wherein the 5-membered heterocycle comprises at least one boron atom; wherein M is selected from the group consisting of Os, Ir, Pd, Pt, Cu, Ag, and Au; and wherein L.sub.A does not comprise a structure of Formula I.

##STR00001##

wherein X is B or N; with the proviso that the 5-membered heterocycle does not comprise a B—B bond; and with the proviso that if M is Pd or Pt and the 5-membered heterocycle is fused to a benzene ring, the benzene ring is not part of a 6-membered chelate ring comprising M. Also provided are formulations comprising these compounds. Further provided are OLEDs and related consumer products that utilize these compounds.

Provided are compounds comprising a first ligand L.sub.A; wherein L.sub.A comprises a 5-membered heterocycle joined to a metal M by a M-C or M-N bond; wherein the 5-membered heterocycle comprises at least one boron atom; wherein M is selected from the group consisting of Os, Ir, Pd, Pt, Cu, Ag, and Au; and wherein L.sub.A does not comprise a structure of Formula I.

##STR00001##

wherein X is B or N; with the proviso that the 5-membered heterocycle does not comprise a B—B bond; and with the proviso that if M is Pd or Pt and the 5-membered heterocycle is fused to a benzene ring, the benzene ring is not part of a 6-membered chelate ring comprising M. Also provided are formulations comprising these compounds. Further provided are OLEDs and related consumer products that utilize these compounds.

A liquid component for an electrolytic capacitor includes at least one central atom selected from the group consisting of boron, aluminum, and silicon, and a ligand having a plurality of ligand atoms bonded to the central atom. The ligand atoms are at least one selected from the group consisting of oxygen and nitrogen, and are bonded to a carbon atom having no oxo group.

The present invention relates to compounds of the formula (1) which are suitable for use in electronic devices, in particular organic electroluminescent devices, and to electronic devices which comprise these compounds.

Disclosed is a biarylamide compound as a Pan-RAF kinase inhibitor, and specifically disclosed are a compound as shown in formula (III) and a pharmaceutically acceptable salt thereof.

##STR00001##

A compound represented by the following general formula has excellent light-emitting characteristics and emits light at a short wavelength. Y.sup.1 is N—R.sup.A; Y.sup.2 is O, S, C═O or N—R.sup.A; R.sup.A is an aryl group, etc.; R.sup.1 to R.sup.11 each are a hydrogen atom or a substituent; at least one of R.sup.1 to R.sup.3 is a carbazolyl group substituted with an aryl group, etc.

##STR00001##

The present invention provides oxaborole ester compounds and compositions thereof which are useful to treat diseases associated with parasites, such as Chagas Disease and African Animal Trypanosomosis.

The present invention relates to a phenyl-derivative compound substituted with at least two electron acceptors and at least two electron donors. Formula (I) R.sup.AaR.sup.DbR.sup.ScC.sub.6 wherein a is 2, 3 or 4; b is 2, 3 or 4; c is 0, 1 or 2; a+b−c=6; R.sup.A is at each occurrence independently a group with −M-effect; R.sup.B is at each occurrence independently a group with +−M-effect; R.sup.S is as defined in claim 1. Said compound is suited for use in organic electronic devices, particularly in organic electroluminescent devices.

An organic molecule is disclosed having a structure of Formula I: ##STR00001##
wherein X is O or S; Y is O or S; R.sup.1 is selected from the group consisting of: hydrogen, deuterium, C.sub.1-C.sub.5-alkyl, which is optionally substituted with one or more substituents R.sup.5; C.sub.6-C.sub.60-aryl, which is optionally substituted with one or more substituents R.sup.5; and C.sub.3-C.sub.57-heteroaryl,
which is optionally substituted with one or more substituents R.sup.5.

An organic molecule is disclosed having a structure of Formula I: ##STR00001##
wherein X is O or S; Y is O or S; R.sup.1 is selected from the group consisting of: hydrogen, deuterium, C.sub.1-C.sub.5-alkyl, which is optionally substituted with one or more substituents R.sup.5; C.sub.6-C.sub.60-aryl, which is optionally substituted with one or more substituents R.sup.5; and C.sub.3-C.sub.57-heteroaryl,
which is optionally substituted with one or more substituents R.sup.5.